BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11225675)

  • 1. Validated method for the determination of platinum from a liposomal source (SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry.
    Meerum Terwogt JM; Tibben MM; Welbank H; Schellens JH; Beijnen JH
    Fresenius J Anal Chem; 2000 Feb; 366(3):298-302. PubMed ID: 11225675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry.
    Brouwers EE; Tibben MM; Joerger M; van Tellingen O; Rosing H; Schellens JH; Beijnen JH
    Anal Bioanal Chem; 2005 Aug; 382(7):1484-90. PubMed ID: 15952001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of total platinum in plasma and plasma ultrafiltrate, from subjects dosed with the platinum-containing N-(2-hydroxypropyl)methacrylamide copolymer AP5280, by use of graphite-furnace Zeeman atomic-absorption spectrometry.
    Tibben MM; Rademaker-Lakhai JM; Rice JR; Stewart DR; Schellens JH; Beijnen JH
    Anal Bioanal Chem; 2002 Jul; 373(4-5):233-6. PubMed ID: 12110973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
    Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
    Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models.
    Bandak S; Goren D; Horowitz A; Tzemach D; Gabizon A
    Anticancer Drugs; 1999 Nov; 10(10):911-20. PubMed ID: 10630359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of platinum originated from antitumoral drugs in human urine by atomic absorption spectrometric methods.
    da Costa AC; Vieira MA; Luna AS; de Campos RC
    Talanta; 2010 Oct; 82(5):1647-53. PubMed ID: 20875558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of platinum complexes in clinical samples by a rapid flameless atomic absorption spectrometry assay.
    Kloft C; Appelius H; Siegert W; Schunack W; Jaehde U
    Ther Drug Monit; 1999 Dec; 21(6):631-7. PubMed ID: 10604824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an AAS method for the determination of platinum in biological fluids from patients receiving the oral platinum derivative JM216.
    Vouillamoz-Lorenz S; Bauer J; Lejeune F; Decosterd LA
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):465-75. PubMed ID: 11377026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry.
    Milacic R; Cemazar M; Sersa G
    J Pharm Biomed Anal; 1997 Oct; 16(2):343-8. PubMed ID: 9408853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of intact cisplatin and its metabolite monohydrated cisplatin in human plasma.
    Verschraagen M; van der Born K; Zwiers TH; van der Vijgh WJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 772(2):273-81. PubMed ID: 12007772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
    Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
    Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of enloplatin by liquid chromatography and of platinum by atomic absorption spectrometry in various biological fluids.
    Amorusi P; Lessard D; Bansal SK; Selinger K; Yacobi A; Tonelli AP
    J Pharm Biomed Anal; 1994 Aug; 12(8):1023-33. PubMed ID: 7819376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate.
    Andrews PA; Wung WE; Howell SB
    Anal Biochem; 1984 Nov; 143(1):46-56. PubMed ID: 6099065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin.
    Veal GJ; Griffin MJ; Price E; Parry A; Dick GS; Little MA; Yule SM; Morland B; Estlin EJ; Hale JP; Pearson AD; Welbank H; Boddy AV
    Br J Cancer; 2001 Apr; 84(8):1029-35. PubMed ID: 11308249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
    Sasaki Y; Tamura T; Eguchi K; Shinkai T; Fujiwara Y; Fukuda M; Ohe Y; Bungo M; Horichi N; Niimi S
    Cancer Chemother Pharmacol; 1989; 23(4):243-6. PubMed ID: 2647312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallomics in drug development: characterization of a liposomal cisplatin drug formulation in human plasma by CE-ICP-MS.
    Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
    Anal Bioanal Chem; 2013 Feb; 405(6):1845-54. PubMed ID: 23052859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum(II).
    Bannister SJ; Chang Y; Sternson LA; Repta AJ
    Clin Chem; 1978 Jun; 24(6):877-80. PubMed ID: 657475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.